AIDS Treatment News index, 2003.

AIDS Treatment News
Index, 2003

Abacavir+tenofovir+3TC failure                        393
Abbott raises Norvir price five fold                  397
Access for all, Thailand conference theme             395
ADAP organizing                                       388
ADAP Washington trip                                  397
Aegis                                                 388
Africa Action                                         390
Africa trials--no drugs                               391
African-Americans and AIDS Conference                 388
African-Americans and AIDS Conference                 397
AIDS Treatment News online publication                397
AIDS Treatment News                                   396
                                           800-TREAT- 1-2
Antibiotic-resistant staph                            388
Atazanavir (Reyataz) approvee                         392
Bahamas antiretroviral prices, Clinton                389
Biomedical research cuts                              392
Bush AIDS initiative                                  388
Bush AIDS initiative                                  391
Buyers' club lists                                    397
Cholesterol management                                394
Ciasullo, Eric, on returning to work                  395
Clinical Care Options for Hepatitis                   391
Clinical Care Options                                 388
Clinton Foundation lowers Caribbean price             389
Clinton Foundation, HAART 40 cents/day                395
Cohen, Dr. Cal, on Retroviruses conf., pt 1           389
Cohen, Dr. Cal, on Retroviruses conf., pt 2           390
Co-trimoxazole for staph                              388
Counterfeit Procrit                                   389
Deep salvage                                          390
Drug development                                      397
Efavirenz vs. nevirapine                              389
Emtriva (FTC) approved                                393
Export problem, WTO                                   394
Federal policy problems                               392
Fosamprenavir approved                                395
FTC (Emtriva) approved                                393
Fundraising, online                                   392
FUZEON (T-20)                                         389
Glaxo research grants                                 391
Global Fund to Fight AIDS, TB, and Malaria            388
Grassroots organizing                                 388
Heart disease guidelines                              394
Highly experienced patients                           390
HIV Insite                                            388
HIV nutrition info for doctors                        391
HIV treatment guidelines, July                        393
HIV treatment guidelines, November 2003               396
HIVandHepatitis.com                                   388
Hoffmann-La Roche, T-20                               389
Huge price variations in generics                     391
IAS conference reports on Web                         393
International AIDS Society conf., Paris               392
Lexiva (908, Fosamprenavir)                           389
Lexiva approved                                       395
Medicaid cuts planned                                 390
Medicaid organizing                                   388
Medscape                                              388
Microbicides                                          391
MRSA                                                  388
NATAP                                                 388
Nelson Mandela on HIV treatment acess                 393
Neuropathy treatment, new guidelines                  396
Nevirapine reduced maternal transmission              394
Nevirapine toxicity                                   389
Nevirapine vs. efavirenz                              389
Norvir price fivefold rise                            397
Paris conference reports on Web                       393
Pediatric HIV guidelines, November2003                396
Pharmaceutical company lobbying facts                 397
Pharmacy benefits managers, profit                    391
Philadelphia FIGHT                                    391
Planetwork conference                                 392
Pneumocystis still cause of death in U.S.             391
Prevention policy problems                            392
Prices of drugs                                       391
Prison Health News                                    390
Prison skin infections                                388
Retroviruses conference, Web coverage                 388
Returning to work after disability                    395
Reyataz approved                                      392
Safety net failure                                    391
SARS Web information                                  390
Save ADAP committee                                   397
Search for a Cure, clinical trials forum              395
Social network software, for fundraising              392
Social Security disability definition                 392
Staph infection treatments                            388
Starting antiretroviral therapy                       389
Subscriptions to share                                396
T-20 cost                                             389
TAC (Treatment Action Campaign)                       390
Tenofovir+ddI+3TC failure                             395
Thailand conference 2004, deadlines                   395
The Body web site                                     388
Treatment Action Campaign                             390
Treatment interruption                                390
Treatment interruption                                394
Triglycerides management                              394
Trizivir arm stopped in trial                         390
UNAIDS report for 2003                                396
VaxGen's AIDSVAX trial                                389
World AIDS $4.7 billion, WorldCom $35B                396
World Trade Organization rules                        394
WORLD, women and HIV                                  391
WTO rules limit access to poor countries              394